Back to Search
Start Over
The University of Tokyo, RIKEN, Nichi-Iko & Daiichi Sankyo ink collaborative R&D on nafamostat inhalation formulation to treat COVID-19
- Source :
- PharmaBiz. June 9, 2020
- Publication Year :
- 2020
-
Abstract
- Byline: Tokyo The University of Tokyo, RIKEN, Nichi-Iko Pharmaceutical Co., Ltd. and Daiichi Sankyo Company, Limited have reached a basic agreement on collaborative R&D on a nafamostat inhalation formulation for [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.626136934